Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, and IgniteData, a leader in intelligent clinical trial data automation, today announced a new ...

The AI-powered clinical trial site feasibility market presents significant growth opportunities through the integration of ...

Advarra and IgniteData have announced a new partnership, enabling secure clinical data transfer between research sites’ instances of Advarra's eSource and electronic data capture (EDC) solutions, ...

The eClinical Solutions Market is booming due to rising R&D investments and demand for faster drug development. Key ...

Advarra and IgniteData have formed a partnership to facilitate secure transfer of clinical trial data between research sites’ ...

To address these challenges head-on, SAS – a global leader in clinical research analytics – today announced the general ...

While digital twins have progressed, there are still a range of ethical, regulatory and data-driven hurdles that must be ...

MALVERN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- YPrime, a proven leader in clinical trial technology, today announced the launch of its Advanced eCOA Oversight functionality—a key enhancement to its ...

Through this deepened collaboration, CTI is accredited in Medidata eCOA to further improve data collection capabilities, enhancing the clinical trial experience for patients by enabling the collection ...

Thermo Fisher Scientific has agreed to acquire Clario Holdings for up to $9.4 billion in cash and future-earnout payments.

New functionality aligns with EMA, FDA, and ICH E6, a proven leader in clinical trial technology, today announced the launch of its Advanced eCOA Oversightfunctionality-a key enhancement to its eCOA p ...

Weight loss at the time of GLP-1 discontinuation was 10.1% overall, 9.7% for those with T2D, and 11.1% for those without.